Xmark Opportunity Partners, LLC

Avg. Two Year Performance

3% Avg. Purchase Return
2% Compound
1% Avg. Sale Return
1% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%(8%)(25%)(39%)3%
Purchase Success Rate8 of 247 of 245 of 248 of 2415 of 24
Average Sale Return(10%)(12%)11%(3%)1%
Sale Success Rate0 of 20 of 21 of 20 of 21 of 2

Genaera Corp.

Drugs » Biotechnology

10% Owner:

Holdings: 2.8M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Aeolus Pharmaceuticals Inc.

Drugs » Drug Manufacturers - Other

10% Owner:

Holdings: 96.93M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--